Vitestro Raises $70M In Series B To Expand Autonomous Blood-Draw Robot In Europe, Eyes US Approval

 
• By Marion Webb
  
VItestro's blood draw system has already been used in more than 10,000 patients worldwide. (Norbert Waalboer/Vitestro)

More from Digital Technologies

More from Medtech Insight